| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-13 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |